Ezio Bonvini
Vermogen: 741 338 $ op 31-08-2026
Vermogen: 741 338 $ op 31-08-2026
Dr. Ezio Bonvini, MD, is a Chief Scientific Officer & Senior VP-Research at MacroGenics, Inc. Dr. Bonvini was previously employed as a Chief-Laboratory Of Immunobiology by Center for Biologics Evaluation & Research, a Principal by National Cancer Institute, a Principal by National Institutes of Health, and a Principal by US Food & Drug Administration.
He received his undergraduate degree from Scientific Lyceum Cassini and a doctorate degree from the University of Genoa School of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MACROGENICS, INC. 0,29% | 17-08-2026 | 185.799 ( 0,29% ) | 741 338 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MACROGENICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2003 |
| Bedrijven | Functie | Einde |
|---|---|---|
Center for Biologics Evaluation & Research
Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to promote safe and appropriate use of biological products | Corporate Officer/Principal | 01-01-2003 |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
MacroGenics, Inc.
MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Center for Biologics Evaluation & Research
Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to promote safe and appropriate use of biological products | Commercial Services |
University of Genoa School of Medicine
University of Genoa School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scientific Lyceum Cassini
Scientific Lyceum Cassini Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau